NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-11

AUTHORS

Chunjing Bian, Chao Zhang, Tao Luo, Aditi Vyas, Shih-Hsun Chen, Chao Liu, Muzaffer Ahmad Kassab, Ying Yang, Mei Kong, Xiaochun Yu

ABSTRACT

ADP-ribosylation is a unique posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) using NAD+ as ADP-ribose donor. PARPs play an indispensable role in DNA damage repair and small molecule PARP inhibitors have emerged as potent anticancer drugs. However, to date, PARP inhibitor treatment has been restricted to patients with BRCA1/2 mutation-associated breast and ovarian cancer. One of the major challenges to extend the therapeutic potential of PARP inhibitors to other cancer types is the absence of predictive biomarkers. Here, we show that ovarian cancer cells with higher level of NADP+, an NAD+ derivative, are more sensitive to PARP inhibitors. We demonstrate that NADP+ acts as a negative regulator and suppresses ADP-ribosylation both in vitro and in vivo. NADP+ impairs ADP-ribosylation-dependent DNA damage repair and sensitizes tumor cell to chemically synthesized PARP inhibitors. Taken together, our study identifies NADP+ as an endogenous PARP inhibitor that may have implications in cancer treatment. More... »

PAGES

693

References to SciGraph publications

  • 2007-08-13. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs in ONCOGENE
  • 2014-07-21. Family-wide analysis of poly(ADP-ribose) polymerase activity in NATURE COMMUNICATIONS
  • 2010-08-10. Making the best of PARP inhibitors in ovarian cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2012-06-20. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs in NATURE REVIEWS MOLECULAR CELL BIOLOGY
  • 2005-04. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy in NATURE
  • 2016-08-17. PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2BGlu2 in NATURE COMMUNICATIONS
  • 2016-01-25. Functional annotation of rare gene aberration drivers of pancreatic cancer in NATURE COMMUNICATIONS
  • 2000-02. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase in NATURE
  • 2012-09-28. The NAD metabolome — a key determinant of cancer cell biology in NATURE REVIEWS CANCER
  • 2013-08-18. Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome in NATURE METHODS
  • 2016-12-13. Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2014-06-05. New PARP targets for cancer therapy in NATURE REVIEWS CANCER
  • 2005-04. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase in NATURE
  • 2016-09-30. Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue in NATURE COMMUNICATIONS
  • 2010-03-04. PARP inhibition: PARP1 and beyond in NATURE REVIEWS CANCER
  • 2011-12-23. BRCA1 and BRCA2: different roles in a common pathway of genome protection in NATURE REVIEWS CANCER
  • 2004-07-16. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2017-11-29. PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers in GYNECOLOGIC ONCOLOGY RESEARCH AND PRACTICE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41467-019-08530-5

    DOI

    http://dx.doi.org/10.1038/s41467-019-08530-5

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1112059739

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30741937


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "ADP-Ribosylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Damage", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Repair", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fanconi Anemia Complementation Group Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NAD", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NADP", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ovarian Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphotransferases (Alcohol Group Acceptor)", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly ADP Ribosylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly(ADP-ribose) Polymerase Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly(ADP-ribose) Polymerases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA Helicases", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bian", 
            "givenName": "Chunjing", 
            "id": "sg:person.01052440324.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052440324.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of General Surgery of Xuanwu Hospital, Capital Medical University, 100053 Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.24696.3f", 
              "name": [
                "Department of General Surgery of Xuanwu Hospital, Capital Medical University, 100053 Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhang", 
            "givenName": "Chao", 
            "id": "sg:person.0776105133.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776105133.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vascular Surgery Department of Xuanwu Hospital, Institute of Vascular Surgery, Capital Medical University, 100053 Beijing, China", 
              "id": "http://www.grid.ac/institutes/grid.24696.3f", 
              "name": [
                "Vascular Surgery Department of Xuanwu Hospital, Institute of Vascular Surgery, Capital Medical University, 100053 Beijing, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Luo", 
            "givenName": "Tao", 
            "id": "sg:person.01247642330.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247642330.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vyas", 
            "givenName": "Aditi", 
            "id": "sg:person.010751504577.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010751504577.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chen", 
            "givenName": "Shih-Hsun", 
            "id": "sg:person.01370634036.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370634036.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "Chao", 
            "id": "sg:person.01050666000.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050666000.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kassab", 
            "givenName": "Muzaffer Ahmad", 
            "id": "sg:person.01036233310.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036233310.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yang", 
            "givenName": "Ying", 
            "id": "sg:person.0622522745.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622522745.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kong", 
            "givenName": "Mei", 
            "id": "sg:person.01005064545.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005064545.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA", 
              "id": "http://www.grid.ac/institutes/grid.410425.6", 
              "name": [
                "Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yu", 
            "givenName": "Xiaochun", 
            "id": "sg:person.0746521555.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746521555.82"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrc2812", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040684149", 
              "https://doi.org/10.1038/nrc2812"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3181", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016615579", 
              "https://doi.org/10.1038/nrc3181"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms12917", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046295952", 
              "https://doi.org/10.1038/ncomms12917"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2010.116", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022428089", 
              "https://doi.org/10.1038/nrclinonc.2010.116"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.2603", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037744158", 
              "https://doi.org/10.1038/nmeth.2603"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrm3376", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025478850", 
              "https://doi.org/10.1038/nrm3376"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3340", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024251386", 
              "https://doi.org/10.1038/nrc3340"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35001622", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019839382", 
              "https://doi.org/10.1038/35001622"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature03445", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039649759", 
              "https://doi.org/10.1038/nature03445"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1210617", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031480740", 
              "https://doi.org/10.1038/sj.onc.1210617"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature03443", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036499081", 
              "https://doi.org/10.1038/nature03443"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms10500", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023654384", 
              "https://doi.org/10.1038/ncomms10500"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2016.191", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018511267", 
              "https://doi.org/10.1038/nrclinonc.2016.191"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3748", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038014944", 
              "https://doi.org/10.1038/nrc3748"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-004-0843-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046606571", 
              "https://doi.org/10.1007/s00280-004-0843-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms5426", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012397541", 
              "https://doi.org/10.1038/ncomms5426"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms12404", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001987728", 
              "https://doi.org/10.1038/ncomms12404"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s40661-017-0055-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1093056003", 
              "https://doi.org/10.1186/s40661-017-0055-8"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-02-11", 
        "datePublishedReg": "2019-02-11", 
        "description": "ADP-ribosylation is a unique posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) using NAD+ as ADP-ribose donor. PARPs play an indispensable role in DNA damage repair and small molecule PARP inhibitors have emerged as potent anticancer drugs. However, to date, PARP inhibitor treatment has been restricted to patients with BRCA1/2 mutation-associated breast and ovarian cancer. One of the major challenges to extend the therapeutic potential of PARP inhibitors to other cancer types is the absence of predictive biomarkers. Here, we show that ovarian cancer cells with higher level of NADP+, an NAD+ derivative, are more sensitive to PARP inhibitors. We demonstrate that NADP+ acts as a negative regulator and suppresses ADP-ribosylation both in vitro and in vivo. NADP+ impairs ADP-ribosylation-dependent DNA damage repair and sensitizes tumor cell to chemically synthesized PARP inhibitors. Taken together, our study identifies NADP+ as an endogenous PARP inhibitor that may have implications in cancer treatment.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41467-019-08530-5", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.8871638", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3806736", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2479594", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.8340548", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2479766", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1043282", 
            "issn": [
              "2041-1723"
            ], 
            "name": "Nature Communications", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "10"
          }
        ], 
        "keywords": [
          "PARP inhibitors", 
          "DNA damage repair", 
          "ovarian cancer cells", 
          "damage repair", 
          "small molecule PARP inhibitors", 
          "PARP inhibitor treatment", 
          "ADP-ribosylation", 
          "DNA damage response", 
          "predictive biomarkers", 
          "ovarian cancer", 
          "unique posttranslational modification", 
          "inhibitor treatment", 
          "therapeutic potential", 
          "cancer types", 
          "tumor cells", 
          "cancer treatment", 
          "potent anticancer drug", 
          "cancer cells", 
          "ADP-ribose donor", 
          "damage response", 
          "posttranslational modifications", 
          "negative regulator", 
          "tumor suppression", 
          "inhibitors", 
          "anticancer drugs", 
          "treatment", 
          "indispensable role", 
          "repair", 
          "NADP", 
          "high levels", 
          "cells", 
          "patients", 
          "cancer", 
          "breast", 
          "NAD", 
          "biomarkers", 
          "drugs", 
          "vivo", 
          "PARP", 
          "polymerase", 
          "regulator", 
          "suppression", 
          "donors", 
          "response", 
          "absence", 
          "levels", 
          "role", 
          "major challenge", 
          "date", 
          "modification", 
          "types", 
          "potential", 
          "implications", 
          "challenges", 
          "derivatives", 
          "molecule PARP inhibitors", 
          "BRCA1/2 mutation-associated breast", 
          "mutation-associated breast", 
          "impairs ADP-ribosylation-dependent DNA damage repair", 
          "ADP-ribosylation-dependent DNA damage repair", 
          "study identifies NADP", 
          "identifies NADP", 
          "endogenous PARP inhibitor"
        ], 
        "name": "NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression", 
        "pagination": "693", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1112059739"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41467-019-08530-5"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30741937"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41467-019-08530-5", 
          "https://app.dimensions.ai/details/publication/pub.1112059739"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:43", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_798.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41467-019-08530-5"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41467-019-08530-5'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41467-019-08530-5'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41467-019-08530-5'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41467-019-08530-5'


     

    This table displays all metadata directly associated to this object as RDF triples.

    360 TRIPLES      22 PREDICATES      128 URIs      100 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41467-019-08530-5 schema:about N087d3e4715d04d3481aec70370ad9bb2
    2 N1ccd97687b2e4ca8812954ba29a61da4
    3 N1e6a0137e74c4685954ef27593d5d17a
    4 N339d220e94a840d6af3ea3f0ad4f0966
    5 N3a8811c8ca3e44f99112f55cdbe67838
    6 N3d91e939ccb143d2a67dea31c0183579
    7 N406005d6416b47429aa4c17fd7c5abc3
    8 N78b010e6754945b19907613339c4d60a
    9 Na842e82dbfa0465cbfc9f8740cbd240f
    10 Na8c725cb120e4b1086e912e918fed233
    11 Naab4eaaf3e204998a05e769791cae626
    12 Nb54c3eeb01594fdca514d4ff6e8097fc
    13 Nb8fb30726e374bfc8b77222a37dd9dc1
    14 Nbcdffce3b4b343d69bf663818b4626ab
    15 Nc9e4b94f38674ced8c3c9cd1f610df1c
    16 Nd353df4608b44eb0a008c415faa05e76
    17 Nd4efd9459caf487585c9aef7a0665193
    18 Ne07fb076cd204d3a926a0be701ec7cfb
    19 Nefd396c8cad84bf79bbe8d94fc481260
    20 anzsrc-for:06
    21 anzsrc-for:0601
    22 anzsrc-for:11
    23 anzsrc-for:1112
    24 schema:author N44b1b425f5e24fa49ef0b4d3dc0ee618
    25 schema:citation sg:pub.10.1007/s00280-004-0843-9
    26 sg:pub.10.1038/35001622
    27 sg:pub.10.1038/nature03443
    28 sg:pub.10.1038/nature03445
    29 sg:pub.10.1038/ncomms10500
    30 sg:pub.10.1038/ncomms12404
    31 sg:pub.10.1038/ncomms12917
    32 sg:pub.10.1038/ncomms5426
    33 sg:pub.10.1038/nmeth.2603
    34 sg:pub.10.1038/nrc2812
    35 sg:pub.10.1038/nrc3181
    36 sg:pub.10.1038/nrc3340
    37 sg:pub.10.1038/nrc3748
    38 sg:pub.10.1038/nrclinonc.2010.116
    39 sg:pub.10.1038/nrclinonc.2016.191
    40 sg:pub.10.1038/nrm3376
    41 sg:pub.10.1038/sj.onc.1210617
    42 sg:pub.10.1186/s40661-017-0055-8
    43 schema:datePublished 2019-02-11
    44 schema:datePublishedReg 2019-02-11
    45 schema:description ADP-ribosylation is a unique posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) using NAD<sup>+</sup> as ADP-ribose donor. PARPs play an indispensable role in DNA damage repair and small molecule PARP inhibitors have emerged as potent anticancer drugs. However, to date, PARP inhibitor treatment has been restricted to patients with BRCA1/2 mutation-associated breast and ovarian cancer. One of the major challenges to extend the therapeutic potential of PARP inhibitors to other cancer types is the absence of predictive biomarkers. Here, we show that ovarian cancer cells with higher level of NADP<sup>+</sup>, an NAD<sup>+</sup> derivative, are more sensitive to PARP inhibitors. We demonstrate that NADP<sup>+</sup> acts as a negative regulator and suppresses ADP-ribosylation both in vitro and in vivo. NADP<sup>+</sup> impairs ADP-ribosylation-dependent DNA damage repair and sensitizes tumor cell to chemically synthesized PARP inhibitors. Taken together, our study identifies NADP<sup>+</sup> as an endogenous PARP inhibitor that may have implications in cancer treatment.
    46 schema:genre article
    47 schema:inLanguage en
    48 schema:isAccessibleForFree true
    49 schema:isPartOf Na156d3550c3744c4b2c1f95ab28de3ed
    50 Ncfe053c522ee4bb49ca5972bb67e89cd
    51 sg:journal.1043282
    52 schema:keywords ADP-ribose donor
    53 ADP-ribosylation
    54 ADP-ribosylation-dependent DNA damage repair
    55 BRCA1/2 mutation-associated breast
    56 DNA damage repair
    57 DNA damage response
    58 NAD
    59 NADP
    60 PARP
    61 PARP inhibitor treatment
    62 PARP inhibitors
    63 absence
    64 anticancer drugs
    65 biomarkers
    66 breast
    67 cancer
    68 cancer cells
    69 cancer treatment
    70 cancer types
    71 cells
    72 challenges
    73 damage repair
    74 damage response
    75 date
    76 derivatives
    77 donors
    78 drugs
    79 endogenous PARP inhibitor
    80 high levels
    81 identifies NADP
    82 impairs ADP-ribosylation-dependent DNA damage repair
    83 implications
    84 indispensable role
    85 inhibitor treatment
    86 inhibitors
    87 levels
    88 major challenge
    89 modification
    90 molecule PARP inhibitors
    91 mutation-associated breast
    92 negative regulator
    93 ovarian cancer
    94 ovarian cancer cells
    95 patients
    96 polymerase
    97 posttranslational modifications
    98 potent anticancer drug
    99 potential
    100 predictive biomarkers
    101 regulator
    102 repair
    103 response
    104 role
    105 small molecule PARP inhibitors
    106 study identifies NADP
    107 suppression
    108 therapeutic potential
    109 treatment
    110 tumor cells
    111 tumor suppression
    112 types
    113 unique posttranslational modification
    114 vivo
    115 schema:name NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
    116 schema:pagination 693
    117 schema:productId N110406a6d5b243b288dcaf3c4439d503
    118 N8c672745b143473e92c1282c8a8e67b6
    119 Ndef4f71fec7741e598e673e4d3be0fd4
    120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112059739
    121 https://doi.org/10.1038/s41467-019-08530-5
    122 schema:sdDatePublished 2021-12-01T19:43
    123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    124 schema:sdPublisher Ndcb216c7011a4d138c001664b3af3971
    125 schema:url https://doi.org/10.1038/s41467-019-08530-5
    126 sgo:license sg:explorer/license/
    127 sgo:sdDataset articles
    128 rdf:type schema:ScholarlyArticle
    129 N087d3e4715d04d3481aec70370ad9bb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name ADP-Ribosylation
    131 rdf:type schema:DefinedTerm
    132 N110406a6d5b243b288dcaf3c4439d503 schema:name doi
    133 schema:value 10.1038/s41467-019-08530-5
    134 rdf:type schema:PropertyValue
    135 N1ccd97687b2e4ca8812954ba29a61da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Mice
    137 rdf:type schema:DefinedTerm
    138 N1e6a0137e74c4685954ef27593d5d17a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Poly ADP Ribosylation
    140 rdf:type schema:DefinedTerm
    141 N28c04bd2eef94f8fa9d9f500cc932372 rdf:first sg:person.01036233310.44
    142 rdf:rest Nadde6463261543c78d3c4e131d983820
    143 N339d220e94a840d6af3ea3f0ad4f0966 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name DNA Damage
    145 rdf:type schema:DefinedTerm
    146 N3a8811c8ca3e44f99112f55cdbe67838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Humans
    148 rdf:type schema:DefinedTerm
    149 N3d91e939ccb143d2a67dea31c0183579 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name NAD
    151 rdf:type schema:DefinedTerm
    152 N3e939a75b25447d49e18f5d535c2eef4 rdf:first sg:person.01005064545.45
    153 rdf:rest Nf2b9b92596a94c4ba1c4b0e813ac2f9b
    154 N406005d6416b47429aa4c17fd7c5abc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Ovarian Neoplasms
    156 rdf:type schema:DefinedTerm
    157 N41f428839b0d42489d9084af1d1c117c rdf:first sg:person.0776105133.53
    158 rdf:rest N6f36df97b91c4922a73e72242aa521e6
    159 N44b1b425f5e24fa49ef0b4d3dc0ee618 rdf:first sg:person.01052440324.36
    160 rdf:rest N41f428839b0d42489d9084af1d1c117c
    161 N6f36df97b91c4922a73e72242aa521e6 rdf:first sg:person.01247642330.90
    162 rdf:rest Nd4a596397817494bba3410ac454d8f72
    163 N78b010e6754945b19907613339c4d60a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Animals
    165 rdf:type schema:DefinedTerm
    166 N8c672745b143473e92c1282c8a8e67b6 schema:name dimensions_id
    167 schema:value pub.1112059739
    168 rdf:type schema:PropertyValue
    169 N9f3d7ef8568b4f2b8e847c522964af0a rdf:first sg:person.01050666000.90
    170 rdf:rest N28c04bd2eef94f8fa9d9f500cc932372
    171 Na156d3550c3744c4b2c1f95ab28de3ed schema:volumeNumber 10
    172 rdf:type schema:PublicationVolume
    173 Na842e82dbfa0465cbfc9f8740cbd240f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Poly(ADP-ribose) Polymerases
    175 rdf:type schema:DefinedTerm
    176 Na8c725cb120e4b1086e912e918fed233 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Phosphotransferases (Alcohol Group Acceptor)
    178 rdf:type schema:DefinedTerm
    179 Naab4eaaf3e204998a05e769791cae626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Biomarkers
    181 rdf:type schema:DefinedTerm
    182 Nadde6463261543c78d3c4e131d983820 rdf:first sg:person.0622522745.39
    183 rdf:rest N3e939a75b25447d49e18f5d535c2eef4
    184 Nb54c3eeb01594fdca514d4ff6e8097fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name RNA Helicases
    186 rdf:type schema:DefinedTerm
    187 Nb8fb30726e374bfc8b77222a37dd9dc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name NADP
    189 rdf:type schema:DefinedTerm
    190 Nbcdffce3b4b343d69bf663818b4626ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Cell Line, Tumor
    192 rdf:type schema:DefinedTerm
    193 Nc9e4b94f38674ced8c3c9cd1f610df1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Female
    195 rdf:type schema:DefinedTerm
    196 Ncfe053c522ee4bb49ca5972bb67e89cd schema:issueNumber 1
    197 rdf:type schema:PublicationIssue
    198 Nd353df4608b44eb0a008c415faa05e76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Antineoplastic Agents
    200 rdf:type schema:DefinedTerm
    201 Nd4a596397817494bba3410ac454d8f72 rdf:first sg:person.010751504577.30
    202 rdf:rest Necb89d67b9f848e288b95c6fa6494996
    203 Nd4efd9459caf487585c9aef7a0665193 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name DNA Repair
    205 rdf:type schema:DefinedTerm
    206 Ndcb216c7011a4d138c001664b3af3971 schema:name Springer Nature - SN SciGraph project
    207 rdf:type schema:Organization
    208 Ndef4f71fec7741e598e673e4d3be0fd4 schema:name pubmed_id
    209 schema:value 30741937
    210 rdf:type schema:PropertyValue
    211 Ne07fb076cd204d3a926a0be701ec7cfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Poly(ADP-ribose) Polymerase Inhibitors
    213 rdf:type schema:DefinedTerm
    214 Necb89d67b9f848e288b95c6fa6494996 rdf:first sg:person.01370634036.92
    215 rdf:rest N9f3d7ef8568b4f2b8e847c522964af0a
    216 Nefd396c8cad84bf79bbe8d94fc481260 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Fanconi Anemia Complementation Group Proteins
    218 rdf:type schema:DefinedTerm
    219 Nf2b9b92596a94c4ba1c4b0e813ac2f9b rdf:first sg:person.0746521555.82
    220 rdf:rest rdf:nil
    221 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    222 schema:name Biological Sciences
    223 rdf:type schema:DefinedTerm
    224 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    225 schema:name Biochemistry and Cell Biology
    226 rdf:type schema:DefinedTerm
    227 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    228 schema:name Medical and Health Sciences
    229 rdf:type schema:DefinedTerm
    230 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    231 schema:name Oncology and Carcinogenesis
    232 rdf:type schema:DefinedTerm
    233 sg:grant.2479594 http://pending.schema.org/fundedItem sg:pub.10.1038/s41467-019-08530-5
    234 rdf:type schema:MonetaryGrant
    235 sg:grant.2479766 http://pending.schema.org/fundedItem sg:pub.10.1038/s41467-019-08530-5
    236 rdf:type schema:MonetaryGrant
    237 sg:grant.3806736 http://pending.schema.org/fundedItem sg:pub.10.1038/s41467-019-08530-5
    238 rdf:type schema:MonetaryGrant
    239 sg:grant.8340548 http://pending.schema.org/fundedItem sg:pub.10.1038/s41467-019-08530-5
    240 rdf:type schema:MonetaryGrant
    241 sg:grant.8871638 http://pending.schema.org/fundedItem sg:pub.10.1038/s41467-019-08530-5
    242 rdf:type schema:MonetaryGrant
    243 sg:journal.1043282 schema:issn 2041-1723
    244 schema:name Nature Communications
    245 schema:publisher Springer Nature
    246 rdf:type schema:Periodical
    247 sg:person.01005064545.45 schema:affiliation grid-institutes:grid.410425.6
    248 schema:familyName Kong
    249 schema:givenName Mei
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005064545.45
    251 rdf:type schema:Person
    252 sg:person.01036233310.44 schema:affiliation grid-institutes:grid.410425.6
    253 schema:familyName Kassab
    254 schema:givenName Muzaffer Ahmad
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036233310.44
    256 rdf:type schema:Person
    257 sg:person.01050666000.90 schema:affiliation grid-institutes:grid.410425.6
    258 schema:familyName Liu
    259 schema:givenName Chao
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050666000.90
    261 rdf:type schema:Person
    262 sg:person.01052440324.36 schema:affiliation grid-institutes:grid.410425.6
    263 schema:familyName Bian
    264 schema:givenName Chunjing
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052440324.36
    266 rdf:type schema:Person
    267 sg:person.010751504577.30 schema:affiliation grid-institutes:grid.410425.6
    268 schema:familyName Vyas
    269 schema:givenName Aditi
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010751504577.30
    271 rdf:type schema:Person
    272 sg:person.01247642330.90 schema:affiliation grid-institutes:grid.24696.3f
    273 schema:familyName Luo
    274 schema:givenName Tao
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247642330.90
    276 rdf:type schema:Person
    277 sg:person.01370634036.92 schema:affiliation grid-institutes:grid.410425.6
    278 schema:familyName Chen
    279 schema:givenName Shih-Hsun
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370634036.92
    281 rdf:type schema:Person
    282 sg:person.0622522745.39 schema:affiliation grid-institutes:grid.410425.6
    283 schema:familyName Yang
    284 schema:givenName Ying
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622522745.39
    286 rdf:type schema:Person
    287 sg:person.0746521555.82 schema:affiliation grid-institutes:grid.410425.6
    288 schema:familyName Yu
    289 schema:givenName Xiaochun
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746521555.82
    291 rdf:type schema:Person
    292 sg:person.0776105133.53 schema:affiliation grid-institutes:grid.24696.3f
    293 schema:familyName Zhang
    294 schema:givenName Chao
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776105133.53
    296 rdf:type schema:Person
    297 sg:pub.10.1007/s00280-004-0843-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046606571
    298 https://doi.org/10.1007/s00280-004-0843-9
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1038/35001622 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019839382
    301 https://doi.org/10.1038/35001622
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1038/nature03443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036499081
    304 https://doi.org/10.1038/nature03443
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1038/nature03445 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039649759
    307 https://doi.org/10.1038/nature03445
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1038/ncomms10500 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023654384
    310 https://doi.org/10.1038/ncomms10500
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1038/ncomms12404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001987728
    313 https://doi.org/10.1038/ncomms12404
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/ncomms12917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046295952
    316 https://doi.org/10.1038/ncomms12917
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1038/ncomms5426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012397541
    319 https://doi.org/10.1038/ncomms5426
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1038/nmeth.2603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037744158
    322 https://doi.org/10.1038/nmeth.2603
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1038/nrc2812 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040684149
    325 https://doi.org/10.1038/nrc2812
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1038/nrc3181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016615579
    328 https://doi.org/10.1038/nrc3181
    329 rdf:type schema:CreativeWork
    330 sg:pub.10.1038/nrc3340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024251386
    331 https://doi.org/10.1038/nrc3340
    332 rdf:type schema:CreativeWork
    333 sg:pub.10.1038/nrc3748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038014944
    334 https://doi.org/10.1038/nrc3748
    335 rdf:type schema:CreativeWork
    336 sg:pub.10.1038/nrclinonc.2010.116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022428089
    337 https://doi.org/10.1038/nrclinonc.2010.116
    338 rdf:type schema:CreativeWork
    339 sg:pub.10.1038/nrclinonc.2016.191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018511267
    340 https://doi.org/10.1038/nrclinonc.2016.191
    341 rdf:type schema:CreativeWork
    342 sg:pub.10.1038/nrm3376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025478850
    343 https://doi.org/10.1038/nrm3376
    344 rdf:type schema:CreativeWork
    345 sg:pub.10.1038/sj.onc.1210617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031480740
    346 https://doi.org/10.1038/sj.onc.1210617
    347 rdf:type schema:CreativeWork
    348 sg:pub.10.1186/s40661-017-0055-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093056003
    349 https://doi.org/10.1186/s40661-017-0055-8
    350 rdf:type schema:CreativeWork
    351 grid-institutes:grid.24696.3f schema:alternateName Department of General Surgery of Xuanwu Hospital, Capital Medical University, 100053 Beijing, China
    352 Vascular Surgery Department of Xuanwu Hospital, Institute of Vascular Surgery, Capital Medical University, 100053 Beijing, China
    353 schema:name Department of General Surgery of Xuanwu Hospital, Capital Medical University, 100053 Beijing, China
    354 Vascular Surgery Department of Xuanwu Hospital, Institute of Vascular Surgery, Capital Medical University, 100053 Beijing, China
    355 rdf:type schema:Organization
    356 grid-institutes:grid.410425.6 schema:alternateName Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA
    357 Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA
    358 schema:name Department of Cancer Biology, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA
    359 Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope Medical Center, Duarte, CA 91010 USA
    360 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...